The invention provides methods of treating disease, such as hypercholesterolemia (e.g., by modulating serum lipids, such as cholesterol, low-density lipoproteins, high-density lipoproteins, and triglycerides) and hyperglycemia by administering Bacillus Calmette-Guerin (BCG). Methods of the invention also encompass the use of genomic, proteomic, and metabolomic analyses for determining the likelihood that a patient has disease or will respond to treatment (e.g., with BCG therapy), as well as for determining whether a patient previously administered BCG would benefit from BCG redosing.
本发明提供了治疗疾病的方法,例如高
胆固醇血症(例如通过调节血清脂质,如
胆固醇、低密度脂蛋白、高密度脂蛋白和
甘油三酯)和通过施用卡介苗杆菌(BCG)治疗高血糖症。本发明的方法还包括使用
基因组学、蛋白质组学和代谢组学分析来确定患者患病的可能性或对治疗(如卡介苗治疗)产生反应的可能性,以及确定先前施用卡介苗的患者是否会从卡介苗再给药中获益。